A
IDYA icon

AJOVista’s IDEAYA Biosciences IDYA Stock Holding History

AJOVista’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,778
Closed -$98.8K – 229
2023
Q4 		$98.8K Buy
+2,778
New +$82.9K 0.12% 177

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AJOVista's IDYA Position: Q1 2024 in Review

AJOVista sold out of IDEAYA Biosciences (IDYA) in Q1 2024, closing a stake of 2,778 shares — an estimated $98.8K sold.

AJOVista first reported a position in IDYA in Q4 2023 and held it in 1 quarter. The position peaked at $98.8K in Q4 2023. 204 funds tracked by Wall St. Rank hold IDYA as of Q1 2024.

  • AJOVista reported no remaining IDEAYA Biosciences position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 2,778 IDEAYA Biosciences shares in Q1 2024, an estimated $98.8K.
  • AJOVista first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 1 quarter.
  • AJOVista's IDEAYA Biosciences position peaked at $98.8K in Q4 2023.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.